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Abstract
Objective:  to  evaluate  the  frequency  and  factors  associated  with  vascular  complications  after
pediatric  liver  transplantation.
Method: risk  factors  were  evaluated  in  99  patients  under  18  years  of  age  with  chronic  liver
disease who  underwent  deceased  donor  liver  transplantation  (DDLT)  between  March  of  1995  and
November  of  2009  at  the  Hospital  de  Clínicas  de  Porto  Alegre,  Brazil.  The  variables  analyzed
included  donor  and  recipient  age,  gender,  and  weight;  indication  for  transplant;  PELD/MELD
scores;  technical  aspects;  postoperative  vascular  complications;  and  survival.
Results: vascular  complications  occurred  in  19  patients  (19%).  Arterial  events  were  most  com-
mon,  occurred  earlier  in  the  postoperative  period,  and  were  associated  with  high  graft  loss  and
mortality  rates.  In  the  multivariate  analysis,  the  following  factors  were  identiﬁed:  portal  vein
diameter  ≤  3  mm,  donor-to-recipient  body  weight  ratio  (DRWR),  prolonged  ischemic  time,  and
use  of  arterial  grafts.
Conclusion: the  choice  of  treatment  depends  on  the  timing  of  diagnosis;  however,  in  this  study,
surgical revision  or  correction  produced  worse  outcomes  than  percutaneous  angioplasty.  The
reduction  of  risk  factors  and  early  detection  of  vascular  complications  are  key  elements  to  a
successful  transplantation.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
 Please cite this article as: Orlandini M, Feier FH, Jaeger B, Kieling C, Vieira SG, Zanotelli ML. Frequency of and factors associated with
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Frequência  e  fatores  relacionados  a  complicac¸ões  vasculares  após  transplante
hepático  pediátrico
Resumo
Objetivo:  Avaliar  a  frequência  e  os  fatores  associados  a  complicac¸ões  vasculares  após  trans-
plante hepático  pediátrico.
Método: Os  fatores  de  risco  foram  avaliados  em  99  pacientes  com  mais  de  18  anos  de  idade  com
doenc¸a hepática  crônica  submetidos  a  transplante  hepático  cadavérico  (THC)  entre  marc¸o de
1995  e  novembro  de  2009  no  Hospital  de  Clínicas  de  Porto  Alegre,  Brasil.  As  variáveis  analisadas
incluíram:  idade,  sexo  e  peso  dos  doadores  e  receptores;  indicac¸ão  de  transplante;  escores
PELD/MELD; aspectos  técnicos;  complicac¸ões  vasculares  pós-operatórias;  e  sobrevida.
Resultados: Ocorreram  complicac¸ões  vasculares  em  19  pacientes  (19%).  Os  eventos  arteriais
foram mais  comuns,  tendo  ocorrido  precocemente  no  pós-operatório,  e  foram  associados  a  altas
taxas  de  perda  do  enxerto  e  mortalidade.  Em  uma  análise  multivariada,  foram  identiﬁcados
os  seguintes  fatores:  diâmetro  da  veia  porta  ≤  3  mm,  proporc¸ão  de  peso  do  doador/receptor
(DRWR), tempo  de  isquemia  prolongado  e  uso  de  enxertos  arteriais.
Conclusão:  A  escolha  do  tratamento  depende  do  momento  do  diagnóstico;  contudo,  nessa  série,
a  cirurgia  de  revisão,  ou  correc¸ão  cirúrgica,  produziu  resultados  piores  que  a  angioplastia  per-
cutânea.  A  reduc¸ão  dos  fatores  de  risco  e  a  detecc¸ão  precoce  de  complicac¸ões  vasculares  são
fundamentais  para  um  transplante  bem-sucedido.
©  2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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iver  transplantation  is  an  accepted  treatment  option  for
hildren with  chronic  liver  disease,  with  actuarial  survival
ates of  up  to  80%  in  ﬁve  and  75%  in  ten  years.1 Early
auses of  graft  failure  and  mortality  are  mostly  related  to
ascular complications,  especially  hepatic  artery  thrombo-
is (HAT)  and  portal  vein  thrombosis  (PVT).2 There  are  a
umber of  recognized  risk  factors  for  the  development  of
hese complications  in  the  pediatric  population,  such  as  dis-
repancy between  donor  and  recipient  arterial  and  portal
iameter, surgical  skills,  lower  recipient  weight,3 and  small
ortal vein  diameter.4 There  are  no  consistent  data  regard-
ng these  risk  factors  in  the  pediatric  population  of  Brazil.
The  aim  of  this  study  was  to  assess  the  frequency
f vascular  complications  in  pediatric  patients  undergoing
eceased donor  liver  transplantation  (DDLT)  at  the  Hospi-
al de  Clínicas  de  Porto  Alegre,  Brazil,  and  to  identify  the
actors associated  with  these  complications  and  mortality.
ethods
he  charts  of  99  ﬁrst  liver  transplant  recipients  under
8 years  of  age  who  underwent  DDLT  at  the  Hospital  de
línicas de  Porto  Alegre  between  March  of  1995  and  Novem-
er of  2009  were  retrospectively  reviewed.  The  study  was
pproved by  the  institution’s  ethics  committee.
During  this  period,  128  liver  transplants  were  performed
n 121  children  and  adolescents  (range:  4  months  to  18
ears). Of  these,  29  were  excluded  from  the  sample:  13  who
nderwent emergency  liver  transplantation  due  to  fulminant
epatitis, six  who  received  living  donor  grafts,  and  three
ecause the  preservation  solution  wasn’t  the  University  of
isconsin solution  (UW).  The  exclusion  criteria  were  deﬁned
d
a
p
on  order  to  avoid  comparison  bias  based  on  immunologi-
al or  technical  factors  inﬂuencing  vascular  complications.
he patients  were  split  into  two  groups  for  comparison:
ith vascular  complications  (n  =  19)  and  without  vascular
omplications (n  =  88).  These  data  were  used  for  univariate
nd multivariate  analysis  in  order  to  identify  the  associated
actors.
Recipients were  assessed  for  the  following  variables:
ge, gender,  weight,  transplant  indication,  PELD/MELD
cores, type  of  allograft,  type  of  anastomosis,  vascular
omplications, management  of  these  complications,  and
urvival. Since  data  regarding  graft  weight  was  not  available
or all  patients,  the  donor  weight/recipient  weight  ratio
DRWR) was  assessed.5
The  diagnosis  of  vascular  complications  was  established
y a  minimum  of  two  imaging  modalities  and/or  surgi-
al conﬁrmation.  All  transplants  were  performed  by  the
ame surgical  team,  and  the  piggyback  technique  with  vena
ava preservation  was  the  standard  procedure.  Vascular
nastomosis was  performed  under  3.5  ×  loupe  magniﬁca-
ions. A  PDSTM (Ethicon)  (7-0  polydioxanone  monoﬁlament)
hread was  used  for  arterial  and  portal  sutures,  and  a  non-
bsorbable 5-0  polypropylene  monoﬁlament  was  used  on  the
epatic veins.  Running  stitches  were  used  for  vessels  larger
han 3  mm  in  diameter,  and  simple  interrupted  stitches  for
maller vessels.
Postoperatively, blood  ﬂow  in  the  hepatic  artery,  portal
ein, and  suprahepatic  vena  cava  was  assessed  by  Doppler
ltrasonography (DUS)  of  the  abdomen  once  a  day  during
he ﬁrst  postoperative  week;  every  other  day  on  the  second
eek; and  once  a  week  subsequently,  for  a total  of  30
ays. Outpatient  DUS  follow-up  was  provided  on  the  third
nd sixth  postoperative  months,  and  one  year  after  trans-
lantation. DUS  was  subsequently  performed  once  a  year
r when  patients  developed  clinical  and/or  biochemical
tions
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abnormalities  that  justiﬁed  testing.  When  DUS  suggested
a vascular  complication,  repeat  ultrasound,  angiography,
computerized tomography  (CT)  scan  with  intravenous  con-
trast, and/or  surgery  was  performed  to  conﬁrm  or  discard
the diagnosis.  Vascular  complications  were  classiﬁed  as
arterial (hepatic  artery)  or  venous  (affecting  the  portal
vein or  suprahepatic  vena  cava).  Early  complications  were
deﬁned as  those  occurring  within  30  days  of  transplantation,
whereas late  complications  were  those  that  occurred  after
this period.
Statistical  analysis
Quantitative  data  were  expressed  as  median,  interquartile
range, and  minimum  and  maximum  values,  and  categorical
data were  expressed  as  counts  and  percentages.
Univariate  analysis  was  performed  on  Kaplan-Meier
curves compared  by  the  log-rank  test,  yielding  hazard  ratios,
95% conﬁdence  intervals,  and  their  signiﬁcance.  A  multivari-
ate Cox  model  including  signiﬁcant  variables  (p  <  0.20)  was
constructed and  used  to  adjust  for  confounders.  A  backward
selection procedure  was  performed,  and  all  variables  with
p ≥  0.10  were  removed.  Data  were  analyzed  and  processed
using the  Statistical  Package  for  Social  Sciences  (SPSS),  ver-
sion 17.0.
Results
The  main  indication  for  transplant  was  biliary  atresia
(52.5%), followed  by  hepatitis  of  unknown  etiology  (17.2%)
and autoimmune  hepatitis  (7%).  Median  recipient  weight  was
17.0 kg  (range:  5.0--78.0  kg),  and  the  median  PELD  score
was 9.0  (range:  8.0--57.0).  A  total  of  99  patients  were
included in  the  study;  72  (72.7%)  received  an  entire  liver
and 27  (27.3%)  received  a  reduced  or  split  graft.  Vascular
complications occurred  in  19  (19.2%)  patients.  Median  age,
weight, and  DRWR  in  the  complication  group  were  2.1  years
(range: 0.5--18.6  years),  14.0  kg  (range:  6.0--78.0  kg),  and
1.4 (range:  0.44--2.88),  respectively  (Table  1).
Of  the  19  patients  with  vascular  complications,
16 received  whole-liver  transplants  and  three  received
reduced-size grafts  (two  left  lobes  and  one  right  lobe  and
segment).4 No  patients  with  vascular  complications  received
split grafts.  Vascular  malformations  were  found  in  ﬁve
patients (26.3%),  and  reduced  portal  vein  diameter  (≤  3  mm)
in four  (21%).  Venous  grafts  were  not  used  in  these  cases
because the  graft  wasn’t  always  available  or  because  the
intraoperative evaluation  concluded  that  the  blood  ﬂow
was good.  Two  patients  (10.5%)  needed  grafts  for  arterial
revascularization; in  both  cases,  an  autologous  infrarenal
aortic graft  was  used.  Only  one  patient  had  never  undergone
abdominal surgery  prior  to  transplantation.
The  most  common  complication  was  HAT  (7%).  Five
patients (5%)  developed  PVT,  three  (3%)  had  hepatic  artery
stenosis, and  two  (2%)  had  portal  vein  stenosis.  One  patient
had a  mycotic  aneurysm  of  the  hepatic  artery,  and  one
developed stenosis  of  the  suprahepatic-caval  anastomosis.
Early vascular  complications  were  most  frequent,  occurring
in 11  patients  (57.9%),  with  a  mortality  of  81.8%.  Vascular
complication-free survival  is  shown  in  Fig.  1A.
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In all  patients,  a  diagnosis  of  vascular  complication  was
uggested by  DUS.  The  deﬁnitive  diagnosis  was  established
y repeated  DUS  in  three  patients  (15.8%),  angiography  in
ight (42.1%),  CT  scan  with  intravenous  contrast  in  four
21%), and  reoperation  in  seven  (36.8%).
Clinical  management  with  intravenous  heparin
Liquemine®) and  oral  acetylsalicylic  acid  were  admin-
stered in  six  patients,  with  a  mortality  rate  of  33.3%.
ercutaneous treatment  was  indicated  in  four  patients:
hree underwent  angioplasty  and  two  received  stents.  The
rimary percutaneous  management  was  with  balloon  dilata-
ion; the  stent  was  inserted  when  the  balloon  dilatation
lone was  insufﬁcient.  In  one  case,  the  stent  was  indicated
ecause of  arterial  kinking.  All  percutaneous  interventions
ere successful,  and  all  four  patients  were  alive  at  the  end
f follow-up.  Seven  patients  were  submitted  to  surgery,
ve of  whom  (71.4%)  underwent  thrombectomy  with
eanastomosis. All  died,  including  two  who  were  awaiting
ransplantation. In  the  remaining  two  patients  (28.6%),
e-transplantation (rLT)  was  the  initial  surgical  treatment,
ut neither  survived.
The  outcomes  are  listed  in  Table  2.  One  patient  in
hom rLT  was  indicated  died  before  any  treatment  could
e administered.  Overall  mortality  in  patients  with  vas-
ular complication  was  57.9%,  and  seven  deaths  (36.8%)
ere directly  correlated  to  the  vascular  complication.  Other
auses of  death  were  sepsis,  renal  failure,  pneumonia,  pneu-
othorax, tuberculosis,  intracranial  bleeding,  and  chronic
ejection.
In the  univariate  analysis,  portal  vein  diameter  ≤  3  mm
nd prolonged  ischemic  time  were  signiﬁcant  risk  factors  for
ascular complications  (p  <  0.05).  A  prior  history  of  abdomi-
al surgery  also  had  signiﬁcance  as  a  risk  factor  (p  <  0.20,  HR
.88). The  results  of  univariate  analysis  are  shown  in  Table  1.
Stratiﬁcation  by  graft  type  demonstrated  that  increased
RWR was  a  protection  factor  against  vascular  complications
n patients  receiving  reduced  grafts.  After  adjusting  for  con-
ounders with  Cox  multivariate  analysis,  portal  diameter
 3  mm  (p  =  0.026;  HR  4.51;  Fig.  1B),  DRWR  (p  =  0.072;  HR
.61), prolonged  ischemic  time  (p  =  0.06;  HR  1.26),  and  the
se of  arterial  grafts  (p  =  0.025;  HR  7.82)  remained  as  highly
igniﬁcant risk  factors  for  vascular  complications  (Table  3).
The  survival  of  pediatric  liver  transplant  recipients  who
eveloped vascular  complications  was  signiﬁcantly  lower
Fig. 1B).
iscussion
iver  transplantation  in  the  pediatric  setting  is  technically
hallenging due  to  the  reduced  size  of  the  vasculature  and
iliary tree.  Discrepancies  in  portal  vein  and  hepatic  arterial
iameter between  the  donor  and  recipient  are  expected.1
he  incidence  of  vascular  complications  reported  in  the  lit-
rature varies  widely  among  centers,  but  is  always  higher
han in  adult  samples.6,7
Arterial  complications  are  most  frequent,  occurring  after
% to  9%  of  all  transplants;8,9 the  present  study  corrobo-
ates this  ﬁnding.  Early  HAT  is  the  most  common  arterial
omplication. In  a  systematic  review,  Bekker  et  al.  reported
he incidence  of  early  HAT  in  pediatric  patients  as  8.3%,
ersus 2.9%  in  adult  transplant  recipients  (p  <  0.001).10
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Table  1  Sample  characteristics  and  univariate  analysis.
Variable  VC  No  VC  HR  95%  CI  p
Recipient  (n)  19  80
Age (years)  2.81  (0.5--18.6)  4.5  (0.6-18)  0.99  0.90--1.07  0.737
Gender  (n,  %)
Male 12  (66.7)  37  (46.2)  0.97  0.40--2.4  0.939
Weight  (kg)  14  (6--78)  17  (5-67)  0.99  0.97--1.02  0.573
Prior  abdominal  surgery  (n,  %) 18  (94.7)  62  (77.5)  4.88  0.65--36.59  0.123
Portal  vein  diameter  (n,  %)
≤ 3  mm 4  (21) 5  (6.2) 3.63  1.19--11.05 0.023
> 3  mm 15  (79) 75  (93.7) 1
Transplant  indication  (n,  %)
Biliary  atresia  12  (63.2)  40  (50)  1
Hepatitis  of  unknown  etiology  4  (21)  13  (16.2)  1.01  0.32--1.14  0.992
Other  3  (18.8)  27  (33.7)  0.36  0.1--1.27  0.113
PELD  score  8  (-7--34)  9.5  (-8-57)  0.98  0.95--1.03  0.612
MELD  score  10.5  (3--24)  12  (0-61)  0.99  0.87--1.11  0.825
Donor  (n) 19  79
Age (years)  5  (0.5--47)  12  (0.5-72)  0.95  0.89--1.0  0.084
Gender  (n,  %)
Male 12  (66.7)  54  (67.5)  0.84  0.32--2.24  0.729
DRWR  1.4  (0.5--2.9)  1.6  (0.5--8.8)  0.67  0.44--1.11  0.132
Surgery  (n)
Ischemic  time  (hours)  10.7  (3.5--14.3)  9.4  (2.8-19)  1.15  1.01--1.31  0.034
Allograft  (n,  %)
Whole 16  (84.2)  56  (70)  1.62  0.47--5.58  0.444
DRWR  0.83  0.41--1.66  0.595
Reduced-size  3  (15.8)  24  (30)  1
DRWR 0.04  <  0.01--1.39  0.076
Data expressed as ‘‘median (interquartile range) [range]’’ or as ‘‘number (%).’’
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eCI, conﬁdence interval; DRWR, donor to recipient weight ratio; H
PELD, pediatric model for end-stage liver disease; VC, vascular co
uffy  et  al.  reported  HAT  rates  of  8%  versus  3.9%  in  pedi-
tric and  adult  patients,  respectively,  in  a  sample  of  4,234
ransplants performed  on  3,558  patients  at  the  University  of
alifornia, Los  Angeles,  in  the  United  States.7 Uchida  et  al.
eported an  incidence  of  HAT  of  6.7%  after  LDLT  in  the  pedi-
tric population,  with  a  ten-year  survival  of  78%.3 The  use
f microvascular  techniques  in  arterial  reconstruction  has
iminished  this  complication,  especially  in  children.Patients  with  HAT  are  at  a  higher  risk  of  allograft  loss
53%), morbidity,  and  mortality  (33%).10,12,13 All  events  are
ore severe  in  early  complications.6,9,14 The  fact  that  only
r
t
n
Table  2  Management  of  vascular  complications.
Treatment  Arterial
(n  =  10)
Anticoagulation  (n,  %);  SR  3  (30);  1/3  
Percutaneous  (n,  %);  SR  2  (20);  2/2  
Surgical revision  (n,  %);  SR  4  (40);  0/4  
Primary  rLT  (n,  %);  SR  1  (10);  0/1  
rLT, retransplantation; SR, success rate.zard ratio; MELD, model for end-stage liver disease; p, p-value;
cation.
ne  of  the  patients  with  HAT  survived  may  be  associated
ith late  diagnosis  and  the  lack  of  available  grafts  in  time
or rLT.
Venous complications  are  less  frequent  than  arterial
omplications, and  the  most  common  is  PVT.11 These  ﬁnd-
ngs were  not  different  in  the  present  patients.  Unlike
rterial complications,  venous  events  occur  later.  Ueda
t al.  reported  a  9%  rate  of  portal  vein  complications  in  a
eview of  521  pediatric  patients  who  underwent  LDLT.  Of
he 47  patients  in  the  portal  event  group,  38  were  diag-
osed with  a  complication  3  months  after  transplant.15 Moon
Portal
(n =  5)
Hepatic vein
(n =  2)
3  (43);  3/3
2  (29);  2/2
1  (14);  0/1
1  (14);  0/1
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Fig.  1  A,  Kaplan-Meier  curve  of  vascular  complications  after  orthotopic  liver  transplantation  in  patients  with  portal  vein  (PV)
l  in  
w
ldiameter  >  3  mm  vs.  ≤  3  mm.  B,  Kaplan-Meier  curves  of  surviva
complications (VC).
et  al.  reported  an  11.2%  incidence  of  portal  complications
in another  sample  of  patients  undergoing  LDLT  (n  =  96).
Once again,  most  complications  occurred  3  months  after
transplantation.16 Kawano  et  al.  also  reported  an  incidence
of 9%  of  late  portal  vein  stenosis  following  LDLT;  all  patients
Table  3  Factors  associated  with  vascular  complications
in patients  undergoing  orthotopic  liver  transplantation.  Cox
multivariate  regression  analysis.
Variable  HR  95%  CI  p
Recipient
Portal  vein  diameter
< 3  mm  4.51  1.20--16.95  0.026
> 3  mm  1
DRWR  0.61  0.36--1.04  0.072
Surgery
Ischemic time  (hours)  1.26  1.07--1.49  0.006
Arterial graft 7.82  1.29--47.29  0.025
CI, conﬁdence interval; DRWR, donor to recipient weight ratio;
HR,  adjusted hazard ratio; p = p-value.
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torthotopic  liver  transplant  recipients  with  or  without  vascular
ere  treated  by  interventional  radiology.17 Still  regarding
iving donation,  another  study  reported  an  incidence  of  15%
f portal  complications  in  the  pediatric  group,  associating
ith a  discrepancy  in  portal  vein  diameter.11,18
Portal  vein  hypoplasia  is  one  of  the  main  risk  factors
or vascular  complications  after  pediatric  liver  transplanta-
ion, particularly  in  children  with  biliary  atresia.12 Suzuki
t al.  found  a portal  vein  diameter  of  less  than  3.5  mm
o be  the  single  most  sensitive  and  speciﬁc  predictor  of
ortal stenosis.4 In  a  study  of  71  pediatric  transplant  recip-
ents, Broniszczak  et  al.  reported  a  16.9%  rate  of  vascular
hrombosis, with  PVT  occurring  only  in  patients  with  por-
al hypoplasia.19 In  the  present  study,  four  of  19  patients
ith vascular  complications  (21%)  had  portal  hypoplasia.  Bil-
ary atresia  was  the  primary  liver  disease  in  all  cases.  Unlike
he study  by  Broniszczak,  only  one  of  the  present  patients
ith portal  hypoplasia  developed  PVT  after  transplantation.
evertheless, an  intraoperative  ﬁnding  of  portal  diameter
 3  mm  was  a  statistically  signiﬁcant  predictor  of  vascu-
ar complications  in  the  postoperative  period  (p  =  0.026),
lthough the  number  of  patients  limited  the  accuracy  of
he present  ﬁndings,  which  should  be  interpreted  with  cau-
ion. This  ﬁndings  need  to  be  conﬁrmed  in  other  studies.
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enous  grafts  were  not  used  in  these  cases  because  por-
al ﬂow  was  present  and  considered  adequate  after  Fogarty
alloon portal  vein  dilation.
In  their  study  of  HAT,  Stewart  et  al.  found  an  ischemic
ime of  12  hours  or  more  to  be  a  signiﬁcant  risk  factor  for  vas-
ular complications  (p  <  0.001).20 In  the  present  sample,  four
ut  of  six  patients  with  prolonged  ischemic  time  developed
AT. Lower  body  weight  and  higher  graft  to  recipient  weight
atio (GRWR)  were  also  inﬂicted  as  risk  factors  for  HAT  in  the
ediatric population.3 GRWR  could  not  be  assessed  because
raft weight  wasn’t  available  in  most  cases.  This  data  has
nly been  routinely  collected  in  the  last  5  years.  Lack  of
ppropriate data  is  a  limitation  of  retrospective  studies.
In  order  to  try  to  evaluate  the  impact  of  graft  size  on
ascular complications,  DRWR  was  assessed.  Oh  et  al.  also
ssessed DRWR,  and  noted  that  patients  who  receive  allo-
rafts from  small  donors  have  signiﬁcantly  higher  HAT  rates
p = 0.002).5 In  the  present  study,  a  high  DRWR  was  a pro-
ective factor  after  stratiﬁcation  by  graft  type  (whole  vs.
artial). In  patients  with  reduced-size  grafts,  the  higher  the
RWR, the  lower  the  potential  for  vascular  complications.
his phenomenon  is  believed  to  be  due  to  the  larger  vessel
iameter.
The use  of  arterial  grafts  for  vascular  reconstruction  has
lso been  debated  as  a  risk  factor.  In  the  present  study,
ultivariate analysis  demonstrated  that  patients  requiring
rterial grafts  had  higher  rates  of  vascular  complications
p = 0.025).  A  meta-analysis  conducted  by  Bekker  et  al.
ound four  studies  assessing  the  use  of  arterial  grafts  as  a
isk factor  for  vascular  complications.  In  three  of  these  stud-
es, two  of  which  employed  multivariate  analysis,  arterial
rafts were  indeed  found  to  be  a  risk  factor.5,10,21 A  recent
ublication by  Backes  et  al.  reported  their  experience  with
rterial grafts  in  58  recipients,  38  during  primary  liver  trans-
lantation and  20  rLT.  The  incidence  of  early  HAT  was  6.8%
n primary  liver  transplantation  recipients,  and  none  in  the
LT. Iliac  artery  graft  with  infrarenal  aortic  anastomosis  was
he technique  of  choice;  however,  the  study  wasn’t  ﬁt  for
he evaluation  of  risk  factors.22
At  least  three  modalities  are  available  for  the  treatment
f vascular  complications:  revascularization,  rLT,  or  clinical
anagement. The  choice  depends  on  the  timing  of  diagno-
is. rLT  provides  the  best  outcomes  and  is  the  treatment
f choice  in  most  groups;  however,  it  is  severely  limited  by
he scarcity  of  donors.10,23 In  early  vascular  complications,
ttempts at  emergency  revascularization  through  percuta-
eous intervention  (angioplasty)  or  surgical  re-exploration  is
he ﬁrst  step  in  management,  particularly  in  HAT.24,25 In  the
vent of  irreversible  cell  damage,  rOLT  is  the  only  option.26
evascularization  success  rates  are  approximately  50%.10
hrombectomy  is  not  indicated  in  late-onset  HAT,  which  is
sually complicated  by  ischemia  and  biliary  tract  injury,  and
s thus  best  treated  by  rLT.27 Patients  with  late-onset  PVT  and
ortal hypertension  but  no  liver  function  compromise  may
eneﬁt  from  splenorenal  shunting.  If  intra-hepatic  portal
eins are  permeable,  a  meso-Rex  shunt  may  be  performed
LT is  mandatory  in  early-onset  PVT  with  graft  dysfunction.28
In  the  present  study,  high  mortality  rates  were  observed
n patients  undergoing  revision  of  anastomosis  with
hrombectomy; patients  managed  with  percutaneous  inter-
ention  (angioplasty)  had  better  outcomes.  Few  patients
nderwent rLT,  but  several  died  while  awaiting  theOrlandini  M  et  al.
rocedure,  as  reported  elsewhere.29 In  the  present  sam-
le, the  time  to  rLT  limited  the  results,  since  the  scarcity
f donors  delayed  the  rescue  procedure.  Outcomes  are
ncouraging in  asymptomatic  patients  treated  with  early
evascularization after  incidental  diagnosis  of  vascular
omplications on  DUS.24,25 Graft  survival  rates  after  revas-
ularization are  substantially  higher  in  this  group  than  in
ymptomatic patients  (81.8%  vs.  40%).24
onclusion
espite  technical  progress  in  pediatric  liver  transplantation,
ascular complications  are  still  a  signiﬁcant  determinant  of
llograft loss,  increasing  postoperative  morbidity  and  mor-
ality.
Arterial complications  are  more  common,  occur  early
n the  postoperative  period,  and  are  associated  with  high
ates of  graft  loss  and  patient  mortality.  Conversely,  venous
omplications are  less  frequent,  occur  late  in  the  postoper-
tive period,  and  have  no  signiﬁcant  effect  on  graft  loss  or
ortality rates.
Strategies for  identiﬁcation  and  mitigation  of  risk  fac-
ors, prevention  of  technical  complications,  and  protocols
or early  detection  of  vascular  complications  may  reduce  the
eed for  rLT,  thus  producing  a long-term  positive  effect  on
reatment of  patients  with  end-stage  liver  disease.  Develop-
ent of  these  strategies  is  a  challenge  yet  to  be  overcome.
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